HER2 IQFISH PHARMDX

System, Test, Her-2/neu, Nucleic Acid Or Serum

FDA Premarket Approval P040005 S007

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for modifications to the formulation of the her2 fish pharmdx kit. The device, as modified, will be marketed under the trade name her2 iqfish pharmdx.

DeviceHER2 IQFISH PHARMDX
Classification NameSystem, Test, Her-2/neu, Nucleic Acid Or Serum
Generic NameSystem, Test, Her-2/neu, Nucleic Acid Or Serum
ApplicantDAKO DENMARK A/S
Date Received2011-12-14
Decision Date2012-12-05
PMAP040005
SupplementS007
Product CodeMVD
Advisory CommitteePathology
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product Yes
Applicant Address DAKO DENMARK A/S 42 Produktionsvej 2600 Glostrup DK-26-2600

Supplemental Filings

Supplement NumberDateSupplement Type
P040005Original Filing
S014 2017-03-13 30-day Notice
S013 2016-03-16 30-day Notice
S012 2016-01-08 30-day Notice
S011 2015-08-13 30-day Notice
S010 2013-08-01 30-day Notice
S009 2012-08-24 Normal 180 Day Track
S008 2012-07-11 30-day Notice
S007 2011-12-14 Normal 180 Day Track
S006 2011-12-05 Normal 180 Day Track
S005 2010-04-20 Panel Track
S004 2010-03-10 135 Review Track For 30-day Notice
S003 2008-07-10 Real-time Process
S002 2007-10-29 Real-time Process
S001 2005-08-15 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
05700572032465 P040005 001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.